MFDS — authorised 30 December 1992
- Marketing authorisation holder: KING PHARMS
- Status: likely_approved
🇰🇷 Alocril in South Korea
MFDS authorised Alocril on 30 December 1992
Marketing authorisation
Alocril in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Alocril approved in South Korea?
Yes. MFDS authorised it on 30 December 1992.
Who is the marketing authorisation holder for Alocril in South Korea?
KING PHARMS holds the South Korean marketing authorisation.